M. Radaeva

发表

Ligand Binding Prediction Using Protein Structure Graphs and Residual Graph Attention Networks

Martin Ester, A. Cherkasov, Mohit Pandey, 2022, bioRxiv.

Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy

A. Cherkasov, Xuesen Dong, H. Adomat, 2021, Cancers.

Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus

N. Strynadka, A. Cherkasov, H. Chambers, 2020, The Journal of Biological Chemistry.

Lin28 Regulates Cancer Cell Stemness for Tumour Progression

A. Cherkasov, Xuesen Dong, M. Radaeva, 2022, Cancers.

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics

M. Gleave, F. Ban, A. Cherkasov, 2021, Frontiers in Oncology.

Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors

P. Rennie, F. Ban, Kriti Singh, 2015, Cells.

Discovery of Novel Lin28 Inhibitors to Suppress Cancer Cell Stemness

A. Cherkasov, Xuesen Dong, N. Xie, 2022, Cancers.

The Use of Methods of Computer-Aided Drug Discovery in the Development of Topoisomerase II Inhibitors: Applications and Future Directions

Artem Cherkasov, Mariia Radaeva, Xuesen Dong, 2020, J. Chem. Inf. Model..

Drugging the 'undruggable'. therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.

F. Ban, A. Cherkasov, Michael Hsing, 2021, Drug discovery today.